SIGA TECHNOLOGIES, INC.

(SIGA)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
24.75 USD   -0.16%
08/09SIGA TECHNOLOGIES : Announces BARDA Exercise of Procurement Options Valued at Approximately $26 Million for IV TPOXX® - Form 8-K
PU
08/09U.S. to buy Siga's IV drug worth $26 million to fight monkeypox outbreak
RE
08/09SIGA TECHNOLOGIES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/08/2022 08/09/2022 08/10/2022 08/11/2022 08/12/2022 Date
22.19(c) 22.79(c) 22.9(c) 24.79(c) 24.75(c) Last
13 537 278 17 082 418 9 190 470 13 016 670 7 732 753 Volume
-4.76% +2.70% +0.48% +8.25% -0.16% Change
More quotes
Estimated financial data (e) (USD)
Sales 2020 125 M - -
Net income 2020 56,3 M - -
Net cash position 2020 116 M - -
P/E ratio 2020 10,2x
Yield 2020 -
Sales 2021 134 M - -
Net income 2021 69,5 M - -
Net cash position 2021 101 M - -
P/E ratio 2021 8,29x
Yield 2021 -
Capitalization 1 807 M 1 807 M -
EV / Sales 2020 3,58x
EV / Sales 2021 3,42x
Nbr of Employees 39
Free-Float 56,0%
More Financials
Company
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company’s lead product, TPOXX (oral TPOXX), is an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The Company does not have a manufacturing infrastructure and does not intend to develop one for the manufacture of TPOXX. It uses contract manufacturing organizations (CMOs) to procure... 
Sector
Pharmaceuticals
Calendar
11/10Earnings Release
More about the company
Ratings of SIGA Technologies, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about SIGA TECHNOLOGIES, INC.
08/09SIGA TECHNOLOGIES : Announces BARDA Exercise of Procurement Options Valued at Approximatel..
PU
08/09U.S. to buy Siga's IV drug worth $26 million to fight monkeypox outbreak
RE
08/09SIGA TECHNOLOGIES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/09U.S. to buy Siga's IV drug worth $26 mln to fight monkeypox outbreak
RE
08/09SIGA Announces BARDA Exercise of Procurement Options Valued at Approximately $26 Millio..
AQ
08/09SIGA Technologies, Inc. Announces BARDA Exercise of Procurement Options Valued at Appro..
CI
08/04How worried should we be about the monkeypox health emergency?
RE
08/04SIGA TECHNOLOGIES INC Management's Discussion and Analysis of Financial Condition and ..
AQ
08/04SIGA TECHNOLOGIES : Approximately $9 Million of Product Sales in the Second Quarter, inclu..
PU
08/04SIGA Technologies Posts Higher Q2 Earnings, Revenue
MT
08/04Earnings Flash (SIGA) SIGA TECHNOLOGIES Posts Q2 Revenue $16.7M
MT
08/04Earnings Flash (SIGA) SIGA TECHNOLOGIES Posts Q2 Revenue $16.7M
MT
08/04TRANSCRIPT : SIGA Technologies, Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04SIGA TECHNOLOGIES INC : Results of Operations and Financial Condition, Change in Directors..
AQ
08/04James Antal Provides Notice to SIGA Technologies, Inc. of His Resignation from the Boar..
CI
More news
News in other languages on SIGA TECHNOLOGIES, INC.
08/09SIGA Technologies, Inc. annonce que la BARDA a exercé des options d'achat d'une valeur ..
08/04À quel point devons-nous nous inquiéter de l'urgence sanitaire liée à la variole du sin..
08/04SIGA Technologies affiche des bénéfices et des revenus plus élevés au deuxième trimestr..
08/04Earnings Flash (SIGA) SIGA TECHNOLOGIES affiche un chiffre d'affaires de 16,7 millions ..
08/04Earnings Flash (SIGA) SIGA TECHNOLOGIES affiche un chiffre d'affaires de 16,7 millions ..
More news
Chart SIGA TECHNOLOGIES, INC.
Duration : Period :
SIGA Technologies, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SIGA TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 24,75
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Phillip Louis Gomez Chief Executive Officer
Daniel J. Luckshire Chief Financial Officer & Executive Vice President
Dennis E. Hruby Chief Scientific Officer & Executive VP
Herb Vloedman Chief Information Officer
Tove C. Bolken Senior VP-Operations & Chief Supply Chain Officer
Sector and Competitors
1st jan.Capi. (M$)
SIGA TECHNOLOGIES, INC.229.12%1 807
JOHNSON & JOHNSON-3.37%434 603
ELI LILLY AND COMPANY11.53%292 730
PFIZER, INC.-15.14%281 235
ROCHE HOLDING AG-16.91%275 562
ABBVIE INC.5.32%252 131